Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2010
11/11/2010US20100286245 Identification of novel genes coding for small temporal rnas
11/11/2010US20100286244 RNAi MEDIATED KNOCKDOWN OF NUMA FOR CANCER THERAPY
11/11/2010US20100286243 Mig-7 as a specific anticancer target
11/11/2010US20100286241 Compositions comprising k-ras sirna and methods of use
11/11/2010US20100286239 Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation
11/11/2010US20100286238 Suppression of viruses involved in respiratory infection or disease
11/11/2010US20100286235 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
11/11/2010US20100286234 Pharmaceutical Composition Comprising Anti-Mirna Antisense Oligonucleotides
11/11/2010US20100286231 Method for identifying a renal fibrosis process use of snail- activity-inhibiting compounds in the production of pharmaceutical compositions, method for identifying said inhibiting compounds, said pharmaceutical compositions and applications thereof
11/11/2010US20100286230 Modulation of trpv expression levels
11/11/2010US20100286228 Method of inhibiting intimal hyperplasia
11/11/2010US20100286082 Riboswitches and methods and compositions for use of and with riboswitches
11/11/2010US20100286070 Affinity tag
11/11/2010US20100286067 Glycoconjugation of polypeptides using oligosaccharyltransferases
11/11/2010US20100286064 Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof
11/11/2010US20100286060 Specific binding agents of human angiopoeitin-2
11/11/2010US20100286049 Polycystic kidney disease-related gene and use thereof
11/11/2010US20100286048 Albumin Fusion Proteins
11/11/2010US20100286030 novel bacteriocin from a new streptomyces species
11/11/2010US20100286026 Novel protein
11/11/2010US20100286025 Synthetic apolipoprotein e mimicking polypeptides and methods of use
11/11/2010US20100286022 Edible and biocompatible metal-organic frameworks
11/11/2010US20100285995 Identification and Characterization of Pregnancy-Associated Genetic Signatures and Use Thereof for Diagnosis and Treatment of Breast Cancer
11/11/2010US20100285988 Gamma-Secretase Substrates And Methods Of Use
11/11/2010US20100285982 Immunogenic peptides of influenza virus
11/11/2010US20100285976 Method for detecting ralstonia solanacearum race 3 biovar 2
11/11/2010US20100285971 Traceability of Cellular Cycle Anomalies Targeting Oncology and Neurodegeneration
11/11/2010US20100285598 Novel Artificial Base Pairs and Uses Thereof
11/11/2010US20100285597 Detection of fragments of nectin-1 for the diagnosis of alzheimer's disease
11/11/2010US20100285596 Methods for isolating functionalized macromolecules
11/11/2010US20100285591 Cyclin d polynucleotides, polypeptides and uses thereof
11/11/2010US20100285583 Compounds and methods for inhibiting platelet aggregation
11/11/2010US20100285570 Fluoride processing method
11/11/2010US20100285567 Tat signal peptides for producing proteins in prokaryotes
11/11/2010US20100285566 has superior thermal stability and is obtained by culturing a microorganism belonging to the genus Burkholderia; biosensor for measuring and analyzing glucose concentration of fluids diabetes;
11/11/2010US20100285562 Isocyclomaltooligosaccharide(s), isocyclomaltooligosaccharide-forming enzyme, their preparation and uses
11/11/2010US20100285544 Novel aminotransferase, gene encoding the same, and method of using them
11/11/2010US20100285541 Transaminase biocatalysts
11/11/2010US20100285540 Process for the preparation of (R)-Beta-Arylalanines by coupled Racemase/Aminomutase catalysis
11/11/2010US20100285532 Production of heterologous proteins or peptides
11/11/2010US20100285528 Method, vector and system for expressing polypeptides
11/11/2010US20100285527 Novel Polypeptide, cDNA Encoding the Same, and Use Thereof
11/11/2010US20100285526 Compositions and Methods for Fusion Protein Separation
11/11/2010US20100285511 Transformed cell with enhanced sensitivity to antifungal compound and use thereof
11/11/2010US20100285507 Plasma kallikrein fragments as diagnostic biomarkers for lung cancers
11/11/2010US20100285502 Novel aromatic prenyltransferases, nucleic acids encoding same and uses therefor
11/11/2010US20100285497 Markers of endothelial cells and uses thereof
11/11/2010US20100285489 Method for diagnosing renal diseases or predispositions
11/11/2010US20100285485 Primer, probe, dna chip containing the same and method for detecting human papillomavirus and detection kit thereof
11/11/2010US20100285475 Fused genes
11/11/2010US20100285472 Primers and probes for detection of high risk group geno-type human papillomavirus dna, a qualitative assay method of the same dna using them and a qualitative assay kit of the same dna
11/11/2010US20100285470 Monomethine dyes
11/11/2010US20100285466 Esophageal cancer markers
11/11/2010US20100285465 Molecular Typing of Neisseria Strains by Determining the Presence of Genes Involved in Lipooligosaccharide (LOS) Biosynthesis
11/11/2010US20100285464 A conserved region of the hiv-1 genome and uses thereof
11/11/2010US20100285452 Molecular Markers for the Diagnosis and Treatment of Tumors
11/11/2010US20100285448 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses
11/11/2010US20100285445 Chimeric construct of mungbean yellow mosaic india virus (mymiv) and its uses thereof
11/11/2010US20100285443 Diagnostic Methods for Diseases Caused by a HPV Infection Comprising Determining the Methylation Status of the HPV Genome
11/11/2010US20100285173 Glucose-induced inactivation/degradation-resistant transporter gene and use thereof
11/11/2010US20100285131 Fgf21 mutants and uses thereof
11/11/2010US20100285109 Truncated secretory aspartyl proteinase 2
11/11/2010US20100285104 Compositions and methods for the delivery of oxygen
11/11/2010US20100285073 a micro-rna family that modulates fibrosis and uses thereof
11/11/2010US20100285070 Polynucleotides of haemophilus parasuis and its use
11/11/2010US20100285065 Modified cea nucleic acid and expression vectors
11/11/2010US20100285063 Novel canine influenza virus and vaccine therefore
11/11/2010US20100285056 Baculovirus-Based Vaccines
11/11/2010US20100285052 Chemically Programmable Immunity
11/11/2010US20100285049 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method
11/11/2010US20100285048 Use of flagellin in the immunotherapy of yersinia pestis
11/11/2010US20100285046 Nontoxic ricin mutant compositions and methods
11/11/2010US20100285041 Class A Oligonucleotides with Immunostimulatory Potency
11/11/2010US20100285037 Antibodies to cll-1
11/11/2010US20100285036 Anti-CD100 Neutralizing Antibodies and Methods of Using the Same
11/11/2010US20100285035 High Affinity Antibody Antagonists of Interleukin-13 Receptor Alpha 1
11/11/2010US20100285027 Antibodies specific for human hepcidin
11/11/2010US20100285022 Anti-rsv g protein antibodies
11/11/2010US20100285017 Matriptase protein and uses thereof
11/11/2010US20100285014 Immunoglobulin fusion proteins
11/11/2010US20100285009 Humanized anti-egfl7 antibodies and methods using same
11/11/2010US20100285004 Anti-CD38 human antibodies and uses thereof
11/11/2010US20100284995 Temperature sensitive mutants of matrix metalloproteases and uses thereof
11/11/2010US20100284990 Compositions and Methods for Making Therapies Delivered by Viral Vectors Reversible for Safety and Allele-Specificity
11/11/2010US20100284971 Modified factor viii and factor ix genes and vectors for gene therapy
11/11/2010US20100284966 Methods and Compositions for Managing Resistance of Hepatitis C Virus to Immunosuppressant
11/11/2010US20100284961 MCP-1 binding nucleic acids
11/11/2010US20100284916 Antibodies Against Human Cytomegalovirus (HCMV)
11/11/2010US20100284913 Methods and compositions for studying, imaging, and treating pain
11/11/2010US20100284910 Novel Method of Diagnosing, Monitoring, Staging, Imaging and Treating Various Cancers
11/11/2010US20100284909 Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins
11/11/2010CA2761106A1 Lipophilic polynucleotide conjugates
11/11/2010CA2760890A1 Anti-cd100 antibodies and methods for using the same
11/10/2010EP2248912A1 High sensitivity assays for pathogen detection using metal-enhanced fluorescence
11/10/2010EP2248902A2 Precise breeding
11/10/2010EP2248820A1 Universal supports for oligonucleotide synthesis
11/10/2010EP2247743A2 Modified leptin polypeptides and their uses
11/10/2010EP2247604A2 Biologically active recombinant human saposin c and psap
11/10/2010EP2247308A1 Adjuvant compositions comprising poly-ic and a cationic polymer
11/10/2010EP1833840B9 Potent lna oligonucleotides for the inhibition of hif-1a
1 ... 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 ... 899